Biostress, founded in 2020 and headquartered in the United Kingdom, is on a mission to revolutionize workplace stress management. The company's slogan, "Revolutionising workplace stress management using biometric data to improve wellbeing and productivity," encapsulates its innovative approach. Biostress utilizes biometric data to objectively benchmark workplace stress. It then delivers personalized improvements for individual employees and organizations and objectively measures the impact of these programs on wellbeing and performance. The company recently secured a £150.00K grant investment on 28 March 2022 from Innovate UK, signaling investor confidence in its potential to make a meaningful impact in the Health Care industry.
No recent news or press coverage available for Biostress.